Navigation Links
Stem Cell Bank In UK Would Require 150 Embryo-Derived Stem Cell Lines

A results of a study conducted in Britain to project stem cell requirements for the establishment of a therapeutic stem cell bank has concluded that approximately 150 embryo-derived stem cell lines would// be required to support the functioning on a daily basis.

Britain, South Korea and the United States represent countries where intensive stem cell research is being carried out. The world's first stem cell bank was established in Britain in the year 2004. Over the next two years, the amount of resources allocated for stem cell research in UK would be doubled to 100 million pounds, a part of which would be used to support functioning of the stem cell bank.

Stem cell banks procure stem cells, store and distribute it for research purposes aimed at treatment of human diseases. This mode of treatment is called stem-cell therapy. Although the effective utilization of this form of therapy cannot be accomplished immediately, results of clinical trials conducted on animal models seem promising.

Currently, there is an increasing focus on stem cell therapy for treatment of neurodegenerative disorders (Parkinson’s disease, Alzheimer’s disease), cancer, diabetes and spinal cord injuries. Furthermore, it is estimated that a large number of stem cell lines would be required to match the recipient demand in most of the cases.

It has been estimated that a one in five recipients would have a good match if the number of potential donors were increased to 150. It would also be sufficient to provide a modest match for about 90% and an intermediate tissue match for about 50 to 70% of patients. Surprisingly, a sub-set of stem cells from 10 human embryos have been identified that could theoretically provide a very good match for about 38% of recipients.

Similar to human organ transplantation, the embryonic stem cells from a therapeutic bank would have to be tested for tissue compatibility to minimise chances of rejection and eliminate need for immunosuppressant drugs. Unlike the one to one donor – patient liver, cardiac and renal transplants being performed currently, a single stem cell line could be exploited to benefit multiple recipients.

Despite potential advantages of stem cell therapy, much progress has not been made due to ethical concerns regarding the source of stem cells. Currently, the stem cells are obtained from spare in-vitro fertilization (IVF) embryos, after a written informed consent has been obtained from potential parent.
'"/>




Related medicine news :

1. Patients Pressure Would Result In Overprescription
2. Smallpox Would Spread Rapidly
3. Legalization Of Euthanasia Would Not Affect Patient’s Trus
4. UN Fears Melting Of Ice Would Concentrate Toxins in the Chinese Water Supply
5. Early Detection Of Primary Liver Cancer Would Save Millions Of Lives
6. NHS Trust Would Soon Take On The Hospital Superbug
7. 60 Million People Would Die Due To NCD In India
8. Inactivation of Rad9 in Tumor Cells Would Be Advantageous In Cancer Therapy
9. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
10. Study Would Pave Way for the Development of New Drugs That Targets TB Proteasome
11. Drugs plus Awareness Would Facilitate Reduction of HIV Infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance ... change designed to further positively impact the health and wellness of our community ... considered it our duty to seriously consider releasing our assets beyond our 5% ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ... manufacturers should be asking before selecting an FDA approval pathway? , How ...
(Date:2/17/2017)... WA (PRWEB) , ... February 17, 2017 , ... ... management organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum ... America's healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  BioDigital, Inc., creators of ... of their 3D body mapping technology with eClinicalWorks, ... new integration will be used to capture and ... of the human body. BioDigital pilots show using ... while also increasing the precision of clinical annotations ...
(Date:2/16/2017)... -- Absorption Systems, a global leader in nonclinical testing ... announce that its Chief Operating Officer, Sid Bhoopathy ... the 2017 Executive Management Award. The award is sponsored ... for their creative management vision, leadership philosophy, innovative strategy ... is on March 8, 2017 at the Ballroom at ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
Breaking Medicine Technology: